Hasil Pencarian  ::  Simpan CSV :: Kembali

"This book introduces the methodology for collection and identification of herbal materials, extraction and isolation of compounds from herbs, in vitro bioassay, in vivo animal test, toxicology, and clinical trials of herbal research. To fully understand and make the best use of herbal medicines requires the close combination of chemistry, biochemistry, biology, pharmacology, and clinical science. Although there are many books about traditional medicines research, they mostly focus on either chemical or pharmacological study results of certain plants. This book, however, covers the systematic study and analysis of herbal medicines in general - including chemical isolation and identification, bioassay and mechanism study, pharmacological experiment, and quality control of the raw plant material and end products"

"David S. Riley’s interest in the history, methodology, and results of homeopathic drug provings came from his study of homeopathy at the Hahnemann College of Homeopathy in Albany, California. The 69 drug homeopathic drug provings published here are the result of his investigation of the research methods of homeopathic drug provings that form part of the basis for prescribing in homeopathy. In Dr. Hahnemann’s time the method by which the treatment profiles of homeopathic remedies were determined was called provings, after the original German word Prüfung, which means "test." Scientific research methods have evolved from the early days of homeopathy and Dr. Riley, in an attempt to improve transparency and reduce bias, has incorporated elements of contemporary research methods such as randomization, blinding, and formal good clinical practice guidelines (GCP) into homeopathic drug provings, while adhering to the general guidelines suggested by Dr. Hahnemann and used by homeopathic practitioners and researchers around the world."

"Batuk merupakan tindakan perlindungan dan pertahanan terhadap infeksi mukosa, zat berbahaya, infeksi pada laring, trakea dan bronkus. Penggunaan obat di fasilitas kesehatan harus sesuai dengan acuan yang berlaku secara nasional yaitu Formularium Nasional. Penelitian ini bertujuan untuk mengevaluasi penggunaan obat batuk pada pasien ISPA di Puskesmas Kota Depok pada tahun 2015. Desain penelitian yang digunakan adalah deskriptif analitik dengan pengambilan data secara retrospektif dari resep pasien, Sistem Informasi Manajemen Puskesmas (SIMPUS), dan Sistem Informasi Pengelolaan Obat (SIPO). Sampel adalah resep pasien ISPA periode Januari hingga Desember 2015. Analisis dilakukan pada resep yang memenuhi kriteria inklusi secara kuantitatif dan kualitatif. Analisis secara kuantitatif dinyatakan dalam DDD dan DDD/1000 pasien/hari. Analisis kualitatif dinyatakan dalam segmen DU90%. Berdasarkan hasil analisis menggunakan Microsoft Excel, urutan puskesmas dengan kuantitas penggunaan obat yang dinyatakan dalam DDD dari yang terbesar adalah Puskesmas Cipayung (59136,33g), Puskesmas Limo (34512,55g), dan Puskesmas Bojongsari (14771.28g). Total kuantitas DDD/1000 pasien/hari pada ketiga puskesmas yaitu gliseril guaiakolat (34,885g), ambroksol (1,92g), sirup ambroksol (0,2692g), tablet dekstrometorfan (0,2692g) dan sirup dekstrometorfan (0,0006g). Obat batuk yang menyusun segmen DU90%, yaitu gliseril guaiakolat. Obat batuk penyusun DU90% tidak sesuai dengan Formularium Nasional.

---

Cough is an act of protection and defense against mucosal infections, harmful substances, infection of the larynx, trachea and bronchi. The drug utilization in health facilities must comply with applicable national reference namely Formularium Nasional. This study aimed to evaluate the use of cough medicine in ARI’spatientsat three primary health care in Depok 2015. This study used descriptive design with retrospectively data collection of patient prescriptions, Primary health care Management Information System (SIMPUS), and Medication Management Information System (SIPO). Analysis was conducted on prescriptions that appropriate with inclusion criteria. Samples are prescribed to patients with ARI’s period January to December 2015. Analyses were performed quantitatively and qualitatively. Quantitative analysis expressed in DDD and DDD/1000 patients/day. Qualitative analysis expressed in DU 90% segment. Based on the analysis using Microsoft Excel, the biggest quantity of drug utilization in DDD were Cipayung primary health care (59136.33g), Limo primary health care (34512.55g), and Bojongsari primary health care (14771.28g). Quantity of DDD/1000 patients/day in the third primary health care were glyceryl guaiakolat (34.885g), ambroksol (1.92g), ambroksol syrup (0.2692g), dextromethorphan tablets (0.2692g) and dextromethorphan syrup (0.0006g). Cough medicines that compose DU 90% segment was Glyceryl Guaiacolat. Cough medicines that compose segment DU 90% were not in accordance with national formulary."

"This book, with the focus on the most advanced cutting-edge breakthroughs, covers all the essential aspects of the field of molecular farming in plants: from expression technologies to downstream processing, from products to safety issues, and from current advances and holdups to future developments. "